Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial comparing durvalumab and tremelimumab versus doxorubicin in advanced/metastatic soft tissue sarcoma (completed).
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall [NA]
A completed study evaluated hypofractionated pre-operative radiation therapy for soft tissue sarcomas of the extremity and chest-wall. Resul…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial evaluating pazopanib with durvalumab for metastatic soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas [Phase 1, Phase 2]
Results from a Phase 1/2 trial evaluating high-dose intravenous ascorbate in combination with preoperative radiation for locally advanced so…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
This Phase 2 pediatric MATCH trial update reports results for tazemetostat in patients with relapsed or refractory solid tumors, non-Hodgkin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma [Phase 2]
Phase 2 trial investigating anlotinib with toripalimab for refractory and advanced soft-tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial update for surufatinib in patients with sarcoma including osteosarcoma and soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas [Phase 2]
Phase 2 multicohort trial evaluating trabectedin with low-dose radiation therapy in advanced/metastatic soft tissue sarcomas and related bon…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide [Phase 1, Phase 2]
Phase 1/2 trial of weekly trabectedin combined with metronomic cyclophosphamide in soft-tissue sarcoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: (SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas [NA]
Clinical trial update for SBRT and ART in pulmonary metastases from soft tissue sarcoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy of doxorubicin in combination with pembrolizumab for soft tissue sarcoma has com…
-
CLINICAL_TRIALS trial_result · 2022-12-19Clinical Trial Update: Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update for cadonilimab in advanced soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas [Phase 2]
Phase 2 trial investigating combined nivolumab and trabectedin in metastatic or inoperable soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma [Phase 3]
A Phase 3 trial for localized high-risk rhabdomyosarcoma and rhabdomyosarcoma-like soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma [Phase 2]
Phase 2 trial investigating anlotinib with radiotherapy for resectable soft tissue sarcoma at high risk of recurrence.
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating ipilimumab plus nivolumab with cryotherapy in soft tissue sarcoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: High Precision RT For Soft-Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating high-precision radiotherapy for soft-tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma [Phase 2]
Phase 2 trial update investigating apatinib mesylate in combination with doxorubicin and ifosfamide for advanced soft-tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases [Phase 1, Phase 2]
A Phase 1b/2 clinical trial evaluating liposomal annamycin in patients with soft tissue sarcoma and pulmonary metastases; current status is …
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma [Phase 2]
Phase 2 trial of pazopanib hydrochloride in advanced angiosarcoma has completed and results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
A clinical trial update for durvalumab in combination with doxorubicin in advanced soft tissue sarcoma (Phase 1/2) with undisclosed status.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule [Phase 4]
A Phase 4 clinical trial assessing Anrotenil hydrochloride capsule as first-line chemotherapy after failure in soft tissue sarcoma has been …
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Fruquintinib in the Treatment of Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update for Fruquintinib in soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma [Phase 3]
Phase 3 trial evaluating Anotinib hydrochloride with Epirubicin vs placebo with Epirubicin for first-line treatment of advanced soft tissue …